Oncolytic Virus Therapy Market Trends, Size, Forecast - 2018-2023
Oncolytic virus therapy is based on the treatment through a virus that infects and kills cancer cells. These oncolytic viruses not only destroy the cancerous cell, also prevents the growth of tumour cells by stimulating the host anti-tumour immune responses. The first oncolytic virus therapy was approved in 2015, it is still is in the nascent stage of being considered as suitable and effective cancer therapy. The first oncolytic virus was the genetically modified herpes simplex virus type I that is Talimogene laherparepvec (T-VEC) that reported to be clinically beneficial for patients with melanoma.
Request a free sample of our report on Oncolytic Virus Therapy Market: https://www.omrglobal.com/request-sample/oncolytic-virus-therapy-market
Oncolytic virus therapy market is anticipated to grow at a decent growth rate during the forecast period. Most of the oncolytic virus therapy in clinical trials are in preclinical phase followed by Phase-I trials. At present, two three oncolytic drugs have been commercialised, however, approximately 48 oncolytic virus therapies are in clinical trials. The factors that are fuelling the growth of the market includes higher incidence and prevalence rate of cancer. Melanoma is one of the cancers that has been prevalent across the US region. The first oncolytic virus success over chemotherapy and radiotherapy have paved ways for developing them for other cancers. The other factors are the side effects associated with conventional cancer therapies. Chemotherapy and radiation therapy cause certain side-effects such as prolonged exposure to radiation may cause skin cancer.
A full report of Oncolytic Virus Therapy Market Is available at https://www.omrglobal.com/industry-reports/oncolytic-virus-therapy-market
Oncolytic Virus Therapy Market Segmentation
By Product
HSV-Based Oncolytic Viruses
Adenoviruses-Based Oncolytic Viruses
Vaccinia Virus-Based Oncolytic Viruses
Vesicular Stomatitis Virus-Based Oncolytic Viruses
Newcastle Disease Virus-Based Oncolytic Viruses
By Application
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others
Competitive Landscape
Regional Analysis
North American
United States
Canada
Europe
UK
Germany
Italy
Spain
France
ROE
Asia Pacific
India
China
Japan
ROAPAC
Rest of the World
Company Profiles
Amgen
BioVex Inc.,
Cold Genesys, Inc.
Crusade Laboratories
Cynvec LLC
Genelux Corp.
JennerRex Co. Ltd
Lokon Pharma AB
MediGene AG
Merck
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/oncolytic-virus-therapy-market
About Us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.
For More Information, Visit https://www.omrglobal.com/
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
